- Jan 31, 2019
Daunorubicin reduces cardiomyopathy risk compared with doxorubicin in childhood cancer survivors
Daunorubicin appeared associated with a lower cardiomyopathy risk than doxorubicin among childhood cancer survivors, according to a...
- Jan 31, 2019
International Research Team Led by Australian Scientists Discover a Potential Way to Treat and Preve
Discovering this link – by which MYCN controls polyamine levels in cancer cells, driving the growth and proliferation of the...
- Jan 24, 2019
Cancer-slaying virus may fight childhood eye tumor
Curing the childhood eye cancer retinoblastoma often comes at a cost. The tumor, which sprouts in the retina and primarily occurs in...
- Jan 24, 2019
New tumor test could guide personalized treatment for children with cancer
Scientists at the University of British Columbia and BC Children's Hospital are the first in Canada to use a new test for pediatric...
- Jan 17, 2019
Engineered immune cells target broad range of pediatric solid tumors in mice
In mouse studies, a Stanford-led team has developed an engineered immune cell that eliminates several types of childhood tumors. The...
- Jan 17, 2019
Researchers identify multiple new subtypes of most common childhood cancer
Researchers used integrated genomic analysis, including RNA sequencing, to define the genomic landscape of B-cell acute lymphoblastic...
- Jan 15, 2019
What Price Do Families Pay When a Child has Cancer?
New research by POGO is linking data from its cancer registry (POGONIS) to copies of Canadian tax returns stored at Statistics Canada....
- Jan 10, 2019
Cardiotoxic childhood cancer treatment boosts heart failure risk at young age
Childhood cancer survivors who received cardiotoxic treatment are at high risk of heart failure at a young age, researchers say. Read...